SEC Form 4 · accession 0001382963-16-000211
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Ann Merrifield
Director
Period of report
Aug 2, 2016
Accepted (ET)
Aug 3, 2016 · 8:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock, par value $0.01F1 | Aug 2, 2016 | A | 6,064 | $0.00 | A | 13,193 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares will vest in full at the 2017 Annual Shareholders Meeting.